Find uplifting stories about heroes, innovations, and solutions
95 results for "mrna"
A self-driving lab just found a game-changing way to deliver mRNA therapies, and it discovered the solution completely on its own. The breakthrough could unlock new treatments for diseases beyond vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.
Scientists have cracked a major puzzle in malaria prevention using mRNA vaccine technology to overcome a natural barrier that weakened previous vaccines. The breakthrough could transform protection against a disease that still causes hundreds of millions of infections each year.
Irish researchers have developed a groundbreaking mRNA vaccine that slashed neuroblastoma tumors by 70% in laboratory mice, offering fresh hope for a childhood cancer that kills 15% of young patients. The innovative treatment could be personalized for each child within weeks.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
Scientists are testing an mRNA vaccine that could be ready before a bird flu pandemic ever starts. Unlike COVID-19, this time we'd have protection waiting on the shelf.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
Scientists at Johns Hopkins Medicine developed a breakthrough mRNA treatment that successfully restored embryo implantation in mice with damaged uterine linings, offering new hope for people struggling with infertility. The therapy targets the womb directly and could help patients who can't achieve pregnancy even with IVF.
A new type of flu shot using mRNA technology just cleared a major hurdle, bringing us closer to better protection against seasonal flu. The same groundbreaking approach that powered COVID vaccines could soon help millions stay healthier each winter.
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
A breakthrough flu vaccine using the same technology that helped end the COVID-19 pandemic just cleared a major hurdle, potentially offering faster protection for millions of seniors. The FDA's expert panel unanimously recommended approval of Moderna's mRNA flu shot for Americans over 50.
Scientists created a breakthrough mRNA treatment that shields insulin-producing cells from immune attacks, potentially preventing type 1 diabetes before it starts. Early tests in mice show the nanoparticle therapy successfully reached target cells and delayed disease progression.
Britain just approved its first domestically manufactured mRNA vaccine, marking a major milestone in pandemic preparedness. The new Moderna facility in Oxfordshire can produce up to 250 million doses per year during health emergencies.
After an unexpected rejection last week, the FDA has reversed course and agreed to review Moderna's new mRNA flu vaccine. Seniors could have a new option to protect against the flu by late 2026.
A new flu vaccine that works 27% better than standard shots won unanimous support from FDA advisors, marking a comeback after political interference nearly blocked its review. The mRNA platform could transform how we fight future flu pandemics.
Showing 20 of 95